Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacin
- 1 July 1985
- journal article
- research article
- Published by Elsevier BV in Metabolism
- Vol. 34 (7), 642-650
- https://doi.org/10.1016/0026-0495(85)90092-7
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Hyperlipidemia in the Pacific Northwest Bell Telephone Company Health Survey. Part 2. Lipoprotein lipid interrelationships.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- Hyperlipidemia in the Pacific Northwest Bell Telephone Company Health Survey. Part 1. Lipoprotein cholesterol and triglyceride concentrations.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983
- The Mechanism of Action of Lipid-Lowering DrugsAngiology, 1982
- Familial Type II Hyperlipoproteinemia with Coronary Heart DiseaseChest, 1981
- COLESTIPOL PLUS NICOTINIC ACID IN TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIAThe Lancet, 1981
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic diseaseAtherosclerosis, 1979
- A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators.Heart, 1978
- Clofibrate and niacin in coronary heart diseasePublished by American Medical Association (AMA) ,1975
- Influence of nicotinic acid on serum cholesterol in manArchives of Biochemistry and Biophysics, 1955